Soaring prices, soaring sales.
Grinberg
L
L
D000480:Alkynes; D019380:Anti-HIV Agents / Q000191:economics*; D000998:Antiviral Agents / Q000191:economics*; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000191:economics; D004349:Drug Packaging; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000191:economics*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000191:economics; D010078:Oxazines / Q000191:economics; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors / Q000191:economics*; D012254:Ribavirin / Q000191:economics; D014481:United States; D000099227:Abacavir
D000480:Alkynes; D019380:Anti-HIV Agents; D000998:Antiviral Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D017320:HIV Protease Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D010078:Oxazines; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D012254:Ribavirin; D000099227:Abacavir; C098320:efavirenz